The role of Mucosal-associated invariant T (MAIT) cells during the innate immune response to Mycobacterium tuberculosis

粘膜相关不变 T (MAIT) 细胞在结核分枝杆菌先天免疫反应中的作用

基本信息

项目摘要

Project Summary/Abstract Charles Kyriakos Vorkas, MD is a Fellow in Infectious Diseases at Weill Cornell Medicine (WCM) and a member of the Glickman Laboratory, Memorial Sloan Kettering Cancer Center (MSKCC) whose research interests focus upon Innate immunity during Mycobacterium tuberculosis (Mtb) infection. He plans to pursue a career as a physician-scientist in the field of Tuberculosis (TB) immunology. This proposal describes a five-year training program that will provide the candidate with the knowledge and technical skills to achieve this goal. In addition to intensive laboratory-based experimental training, the proposal includes regular meetings with an advisory committee of experts, active involvement in academic conferences, and formal coursework. At the end of the period of support, the candidate will be prepared to embark on a career as an independent investigator. Little is known about the host factors that influence clearance of Mtb infection, control of latency or progression to active disease. The candidates' work will focus on the role of mucosal- associated invariant T (MAIT) cells in innate immunity to Mtb using an ex vivo MAIT cell activation assay in Haitian donors. MAIT cells are MR1-restricted lymphocytes that recognize bacterially- derived Vitamin B metabolites and data suggest that they act early at mucosal surfaces during Mtb infection. The candidate will investigate immune correlates of resistance to Mtb infection through analysis of three Haitian cohorts: (1) active TB patients (2) healthy household contacts of TB patients and (3) healthy community volunteers without reported exposure. The candidate will also screen synthetic MR1 ligand analogs for effects on MR1 regulation and MAIT activation and test if they can restrict bacterial growth through priming MAIT cells in a monocyte-derived macrophage co-culture model of Mtb infection. This study proposes to identify immune correlates of innate resistance to Mtb infection, which may have direct translational applications for TB immunotherapy or vaccine design.
项目摘要/摘要 查尔斯·基里亚科斯·沃卡斯,医学博士,威尔康奈尔大学传染病研究员 医学(WCM)和格利克曼实验室成员,纪念斯隆·凯特琳癌症 中心(MSKCC),其研究兴趣集中在分枝杆菌的天然免疫 结核病(Mtb)感染。他计划在以下领域从事内科科学家的职业生涯 结核病免疫学。 该提案描述了一项为期五年的培训计划,该计划将为应聘者提供 实现这一目标所需的知识和技能。除了以密集的实验室为基础 在试验性培训方面,该提案包括定期与 专家,积极参与学术会议和正式的课程作业。在结束时, 在支持期内,候选人将准备以独立人士的身份开始职业生涯 调查员。 对影响结核分枝杆菌感染清除的宿主因素知之甚少,控制 潜伏期或进展为活动性疾病。候选人的工作重点将放在粘膜的作用上- 利用体外MAIT细胞激活实现对结核分枝杆菌的天然免疫 海地捐赠者的化验结果。MAIT细胞是受MR1限制的淋巴细胞,能识别细菌- 衍生的维生素B代谢物和数据表明,它们在早期作用于粘膜表面 结核分枝杆菌感染。 候选人将通过以下途径研究结核分枝杆菌感染的抵抗力的免疫相关性 海地三个队列的分析:(1)活动性结核病患者(2)健康家庭接触者结核病 患者和(3)未报告暴露的健康社区志愿者。 候选人还将筛选合成的MR1配体类似物对MR1的影响 调节和MAIT激活,并测试它们是否可以通过引发MAIT来抑制细菌生长 结核杆菌感染的单核巨噬细胞共培养模型中的细胞。 这项研究建议确定对结核分枝杆菌感染的先天抵抗力的免疫相关性, 它们可能直接用于结核病免疫治疗或疫苗设计的翻译应用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Charles Kyriakos Vorkas其他文献

CD8α marks a Mycobacterium tuberculosis-reactive human NK cell population with high activation potential
  • DOI:
    10.1038/s41598-025-98367-4
  • 发表时间:
    2025-04-29
  • 期刊:
  • 影响因子:
    3.900
  • 作者:
    Nezar Mehanna;Atul Pradhan;Rimanpreet Kaur;Theodota Kontopoulos;Barbara Rosati;David Carlson;Nai-Kong V. Cheung;Hong Xu;James Bean;Katharine C. Hsu;Jean-Benoit Le Luduec;Charles Kyriakos Vorkas
  • 通讯作者:
    Charles Kyriakos Vorkas
Premature Immune Aging in Survivors of Childhood Hematologic Malignancies
  • DOI:
    10.1182/blood-2024-194884
  • 发表时间:
    2024-11-05
  • 期刊:
  • 影响因子:
  • 作者:
    Suguna Raju;Danielle Xie;Rina Meyer;Isabel Hernandez Flores;Samantha Tran;Laura E. Hogan;Christina Y. Lee;Charles Kyriakos Vorkas
  • 通讯作者:
    Charles Kyriakos Vorkas
MR1-Restricted Immunity in Hematologic Malignancy
  • DOI:
    10.1182/blood-2024-194667
  • 发表时间:
    2024-11-05
  • 期刊:
  • 影响因子:
  • 作者:
    Danielle Xie;Rimanpreet Kaur;Arshia Arasappan;Samantha Tran;Sagar Makavana;Kathrene Rylova;Atul Pradhan;Charles Kyriakos Vorkas;Christina Y. Lee
  • 通讯作者:
    Christina Y. Lee

Charles Kyriakos Vorkas的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Charles Kyriakos Vorkas', 18)}}的其他基金

Identification of Mycobacterium tuberculosis-derived metabolites acting as ligands for MR1-restricted T cells.
鉴定作为 MR1 限制性 T 细胞配体的结核分枝杆菌衍生代谢物。
  • 批准号:
    10667695
  • 财政年份:
    2023
  • 资助金额:
    $ 18.43万
  • 项目类别:
The role of Mucosal-associated invariant T (MAIT) cells during the innate immune response to Mycobacterium tuberculosis
粘膜相关不变 T (MAIT) 细胞在结核分枝杆菌先天免疫反应中的作用
  • 批准号:
    10411946
  • 财政年份:
    2018
  • 资助金额:
    $ 18.43万
  • 项目类别:
The role of Mucosal-associated invariant T (MAIT) cells during the innate immune response to Mycobacterium tuberculosis
粘膜相关不变 T (MAIT) 细胞在结核分枝杆菌先天免疫反应中的作用
  • 批准号:
    10163787
  • 财政年份:
    2018
  • 资助金额:
    $ 18.43万
  • 项目类别:

相似国自然基金

Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
  • 批准号:
    2022J011295
  • 批准年份:
    2022
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
  • 批准号:
    30801055
  • 批准年份:
    2008
  • 资助金额:
    19.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Bovine herpesvirus 4 as a vaccine platform for African swine fever virus antigens in pigs
牛疱疹病毒 4 作为猪非洲猪瘟病毒抗原的疫苗平台
  • 批准号:
    BB/Y006224/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.43万
  • 项目类别:
    Research Grant
A novel vaccine approach combining mosquito salivary antigens and viral antigens to protect against Zika, chikungunya and other arboviral infections.
一种结合蚊子唾液抗原和病毒抗原的新型疫苗方法,可预防寨卡病毒、基孔肯雅热和其他虫媒病毒感染。
  • 批准号:
    10083718
  • 财政年份:
    2023
  • 资助金额:
    $ 18.43万
  • 项目类别:
    Small Business Research Initiative
Uncovering tumor specific antigens and vulnerabilities in ETP-acute lymphoblastic leukemia
揭示 ETP-急性淋巴细胞白血病的肿瘤特异性抗原和脆弱性
  • 批准号:
    480030
  • 财政年份:
    2023
  • 资助金额:
    $ 18.43万
  • 项目类别:
    Operating Grants
Regulation of B cell responses to vaccines by long-term retention of antigens in germinal centres
通过在生发中心长期保留抗原来调节 B 细胞对疫苗的反应
  • 批准号:
    MR/X009254/1
  • 财政年份:
    2023
  • 资助金额:
    $ 18.43万
  • 项目类别:
    Research Grant
Adaptive Discrimination of Risk of Antigens in Immune Memory Dynamics
免疫记忆动态中抗原风险的适应性辨别
  • 批准号:
    22KJ1758
  • 财政年份:
    2023
  • 资助金额:
    $ 18.43万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
22-ICRAD Call 2 - Improving the diagnosis of tuberculosis in domestic ruminants through the use of new antigens and test platforms
22-ICRAD 呼吁 2 - 通过使用新抗原和测试平台改善家养反刍动物结核病的诊断
  • 批准号:
    BB/Y000927/1
  • 财政年份:
    2023
  • 资助金额:
    $ 18.43万
  • 项目类别:
    Research Grant
Protective immunity elicited by distinct polysaccharide antigens of classical and hypervirulent Klebsiella
经典和高毒力克雷伯氏菌的不同多糖抗原引发的保护性免疫
  • 批准号:
    10795212
  • 财政年份:
    2023
  • 资助金额:
    $ 18.43万
  • 项目类别:
Integrative proteome analysis to harness humoral immune response against tumor antigens
综合蛋白质组分析利用针对肿瘤抗原的体液免疫反应
  • 批准号:
    23K18249
  • 财政年份:
    2023
  • 资助金额:
    $ 18.43万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Targeting T3SA proteins as protective antigens against Yersinia
将 T3SA 蛋白作为针对耶尔森氏菌的保护性抗原
  • 批准号:
    10645989
  • 财政年份:
    2023
  • 资助金额:
    $ 18.43万
  • 项目类别:
Functionally distinct human CD4 T cell responses to novel evolutionarily selected M. tuberculosis antigens
功能独特的人类 CD4 T 细胞对新型进化选择的结核分枝杆菌抗原的反应
  • 批准号:
    10735075
  • 财政年份:
    2023
  • 资助金额:
    $ 18.43万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了